Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +47.88%
#2 Purr Purr +36.13%
#3 Pons Pons +35.51%
#4 TENDIES TENDIES +29.81%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +29.71%
#6 Starpower Starpower +27.24%
#7 StonkBroker StonkBroker +25.18%
#8 Magma Finance Magma Finance +24.68%
#9 SkyAI SkyAI +23.37%
#10 Kinetiq Kinetiq +22.82%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Yumanity Therapeutics, Inc. Yumanity Therapeutics, Inc.

Yumanity Therapeutics, Inc.

YMTX
Rang in aandelen #28846
Yumanity Therapeutics Inc. operates as a clinical-stage biopharmaceutical... Yumanity Therapeutics Inc. operates as a clinical-stage biopharmaceutical company. Its primary focus lies in the investigation and development of therapeutic solutions for neurodegenerative conditions, particularly those driven by protein misfolding. The firm aims to discover disease-modifying treatments for a range of neurodegenerative disorders, including Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, amyotrophic lateral sclerosis (ALS), and frontotemporal lobar degeneration. Central to its pipeline is YTX-7739, an innovative small molecule presently in Phase I clinical trials for Parkinson's disease and associated α-synuclein disorders. Additionally, YTX-9184 is undergoing preclinical studies with the goal of treating diverse neurological conditions. The company maintains a license and research collaboration agreement with Merck Sharp & Dohme Corp. Founded in 2014, Yumanity Therapeutics Inc. is headquartered in Boston, Massachusetts.
Aandeelprijs
$1.89
Laatst gesynchroniseerd: 2022-12-16
Marktkapitalisatie
$24.38M
Verandering (1 dag)
8.62%
Verandering (1 jaar)
0.00%
Land
US
Handel Yumanity Therapeutics, Inc. (YMTX)

Categorie

Healthcare
EPS voor Yumanity Therapeutics, Inc. (YMTX)
EPS per 2026 TTM: 0
Volgens de laatste financiële rapporten en de aandelenkoers van Yumanity Therapeutics, Inc. is de huidige EPS van het bedrijf (TTM) 0. Eind 2026 had het bedrijf een EPS van 0, gelijk aan de EPS van 2026 die 0 bedroeg.
EPS-geschiedenis van Yumanity Therapeutics, Inc. van 2026 tot 2026
EPS aan het einde van elk jaar
Jaar EPS Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
EPS van vergelijkbare bedrijven of concurrenten
Bedrijf EPS EPS-verschil Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $2.98 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH